Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.
<h4>Introduction</h4>While Dupuytren's disease can cause disabling contractures requiring open surgery, a less-invasive option using Clostridium Histolyticum collagenase (CHC) via percutaneous injection was recently reported. A recent prospective, randomized trial demonstrated few c...
Guardado en:
Autores principales: | Warren M Rozen, Yasith Edirisinghe, John Crock |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04002241ef1741cca7591f8fa249087b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of collagenase clostridium histolyticum in Peyronie's disease
por: Peak TC, et al.
Publicado: (2015) -
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie’s disease in a multicenter clinical study
por: Andrea Cocci, et al.
Publicado: (2021) -
The effect of collagenase clostridium histolyticum on adhesion reduction in a rat knee arthrofibrosis model
por: Nazım Karahan, et al.
Publicado: (2021) -
In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.
por: Farhatullah Syed, et al.
Publicado: (2012) -
Enfermedad de Dupuytren: revisión
por: Wagner,Pablo, et al.
Publicado: (2012)